IP Library Granted Patent US 12,533,485
Granted Patent B2
US 12,533,485 · App. 17/193,258 · Granted Jan 27, 2026

Packaging for hydrated articles and related methods

Inventors: Mark Thomas Doherty (Lynnfield, MA); Daniel T. Donahue (Cambridge, MA); Brian M. Hanley (Reading, MA); Matthew M. Mannarino (Burlington, MA); Michael J. McGrath (Waltham, MA)
Assignee: Access Vascular, Inc.
A61M25/002A61L29/041A61L29/06A61L29/14A61L29/146
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,533,485
App. No.
17/193,258
Granted
Jan 27, 2026
Kind
B2
Abstract

Packaging for hydrated articles are generally provided. In some embodiments, packaged articles are provided. For example, in some embodiments, a container contains an article such as a catheter and/or polymeric material. The disclosed packaged articles may be useful for, for example, providing controlled humidity conditions for contained components, maintaining consistent hydration levels of the packaged articles, and/or improved sterilization conditions. Advantageously, the packaged articles described herein may, in some embodiments, create an environment with minimum relative humidity for long-term storage of a catheter or polymeric material, increase shelf life of the catheter or polymeric material, and/or facilitate hydration of a catheter such that e.g., the catheter hydrates to intended dimensions within a specified amount of time. Methods for preparing such packaged article are also provided.

Claims (38)

1 . A packaged article, comprising:

a container comprising a foil material;

a catheter comprising a polymeric material, the polymeric material having a water content of greater than or equal to 2 w/w % and less than or equal to 40 w/w %; and

a humidity control component comprising a humidity control sponge;

wherein the water content is less than an equilibrium water content of the polymeric material; and

wherein the polymeric material is configured to swell in an amount greater than or equal to 5 w/w % to an equilibrium water content state.

2 . A packaged article as in claim 1 , wherein the foil material is substantially impermeable to water.

3 . A packaged particle as in as in claim 1 , wherein the container is a pouch.

4 . A packaged article as in claim 1 , wherein the container further comprises a vapor permeable polymer.

5 . A packaged article as in claim 1 , wherein the polymeric material comprises poly(vinyl alcohol), poly(acrylic acid), polyethylene glycol, poly(vinyl pyrrolidone), poly(methacrylic sulfobetaine), poly(acrylic sulfobetaine), poly(methacrylic carboxybetaine), poly(acrylic carboxybetaine), povidone, polyacrylamide, poly(N-(2-hydroxypropyl)methacrylamide), polyoxazolines, polyphosphates, polyphosphazenes, polyvinyl acetate, polypropylene glycol, poly(N-isopropylacrylamide), poly(2-hydroxymethylmethacrylate), and combinations thereof.

6 . The packaged article of claim 1 , wherein the polymeric material is configured to swell to the equilibrium water content state in a time period of less than or equal to 60 minutes at 25° C.

7 . The packaged article of claim 1 , wherein the catheter has an inner diameter, an outer diameter, and a length; and wherein the polymeric material is configured to swell such that the inner diameter and/or outer diameter increase by a larger percentage than percentage increase in length.

8 . The packaged article of claim 1 , further comprising a biologically active agent present in the catheter in an amount of greater than or equal to 0.01 w/w % versus a total weight of the catheter.

9 . The packaged article of claim 1 , wherein the polymeric material has a water content of less than 5 w/w % and greater than or equal to 0.1 w/w % in a dehydrated state, and wherein the polymeric material is configured to swell in an amount greater than or equal to 5 w/w % and less than or equal to 50 w/w % from the dehydrated state to the equilibrium water content state in less than or equal to 60 minutes.

10 . The packaged article of claim 1 , wherein the polymeric material has a Young's elastic modulus of greater than or equal to 500 MPa in a dehydrated state and a Young's elastic modulus of less than or equal to 300 MPa and greater than or equal to 5 MPa at an equilibrium water content state.

11 . The packaged article of claim 1 , wherein the catheter has a coefficient of friction of less than or equal to 0.10 at the equilibrium water content state.

12 . The packaged article of claim 1 , wherein the catheter comprises an osmotic agent present in the polymeric material in an amount greater than or equal to 0.05 w/w % and less than or equal to 2 w/w % versus a total catheter weight.

13 . The packaged article of claim 1 , wherein the polymeric material is substantially non-thrombogenic.

14 . The packaged article of claim 1 , wherein the humidity control component further comprises an antiseptic or anti-infective agent.

15 . The packaged article of claim 1 , wherein the humidity control component is configured to be removed from the container.

16 . The packaged article claim 1 , wherein the packaged article comprises a humectant.

17 . The packaged article of claim 16 , wherein the humectant comprises poloxamer, polyethylene glycol, glycerol, propylene glycol, ethylene glycol, butylene glycol, erythritol, threitol, arabitol, xylitol, ribitol, mannitol, sorbitol, galactitol, fucitol, iditol, inositol, volemitol, malitol, lactitol, maltotriitol, maltotetraitol, and/or polyglycitols.

18 . The packaged article of claim 1 , wherein the catheter has a plurality of pores.

19 . The packaged article of claim 18 , wherein the polymeric material comprises a first water soluble polymer and wherein the catheter further comprises a second water soluble polymer that is the same or different than the first water soluble polymer and positioned within at least a portion of the plurality of pores.

20 . The packaged article of claim 19 , wherein the first water soluble polymer does not comprise covalent crosslinking agents.

21 . The packaged article of claim 1 , further comprising hydration media.

22 . The packaged article of claim 21 , wherein the hydration media comprises water, lactated Ringer's solution (LRS), dextrose (D5W), phosphate buffered saline (PBS), and/or Hanks' Balanced Salt Solution (HBSS).

23 . A packaged article, comprising:

a container comprising a foil material;

a polymeric material comprising poly(vinyl) alcohol, the polymeric material having a water content of greater than or equal to 2 w/w % and less than or equal to 40 w/w %; and

a humidity control component comprising a humidity control sponge;

wherein the water content is less than an equilibrium water content of the polymeric material; and

wherein the polymeric material is configured to swell in an amount greater than or equal to 5 w/w % to an equilibrium water content state.

24 . The packaged article of claim 23 , wherein the humidity control component further comprises an antiseptic or anti-infective agent.

25 . A packaged article as in as in claim 1 , comprising a header portion.

26 . A method, comprising:

removing, from the packaged article of claim 1 , the catheter; and

rehydrating the catheter to equilibrium water content.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2023
From: DOHERTY, MARK THOMAS; DONAHUE, DANIEL T.; HANLEY, BRIAN; MANNARINO, MATTHEW M.; MCGRATH, MICHAEL J.
To: ACCESS VASCULAR, INC.
Reel/Frame 063861/0878 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2021
From: DOHERTY, MARK THOMAS; DONAHUE, DANIEL T.; HANLEY, BRIAN M.; MCGRATH, MICHAEL J.; MANNARINO, MATTHEW M.
To: ACCESS VASCULAR, INC.
Reel/Frame 056452/0304 →
Continuity (2)
Provisional Application 62986571 · Mar 6, 2020
Related Publication 20210275774A1 · Sep 9, 2021
References Cited (166)
US 3220960A · Vaclavkova · 1965 [cited by applicant]
US 3566874A · Shepherd et al. · 1971 [cited by applicant]
US 3995623A · Blake et al. · 1976 [cited by applicant]
US 4024873A · Antoshkiw et al. · 1977 [cited by applicant]
US 4026296A · Stoy et al. · 1977 [cited by applicant]
US 4073733A · Yamauchi et al. · 1978 [cited by applicant]
US 4379874A · Stoy · 1983 [cited by applicant]
US 4543102A · Defago et al. · 1985 [cited by applicant]
US 4663358A · Hyon et al. · 1987 [cited by applicant]
US 4943618A · Stoy et al. · 1990 [cited by applicant]
US 5061254A · Karakelle et al. · 1991 [cited by applicant]
US 5225120A · Gravier et al. · 1993 [cited by applicant]
US 5336205A · Zenzen et al. · 1994 [cited by applicant]
US 5443727A · Gagnon · 1995 [cited by applicant]
US 5449382A · Dayton · 1995 [cited by applicant]
US 5485667A · Kleshinski · 1996 [cited by applicant]
US 5508036A · Bakker et al. · 1996 [cited by applicant]
US 5523335A · Whyzmuzis et al. · 1996 [cited by applicant]
US 5578075A · Dayton · 1996 [cited by applicant]
US 5601538A · Deem · 1997 [cited by applicant]
US 5679400A · Tuch · 1997 [cited by applicant]
US 5688459A · Mao et al. · 1997 [cited by applicant]
US 5820918A · Ronan et al. · 1998 [cited by applicant]
US 5928279A · Shannon et al. · 1999 [cited by applicant]
US 6099562A · Ding et al. · 2000 [cited by applicant]
US 6231605B1 · Ku · 2001 [cited by applicant]
US 6271278B1 · Park et al. · 2001 [cited by applicant]
US 6656206B2 · Corcoran et al. · 2003 [cited by applicant]
US 6706024B2 · Modak et al. · 2004 [cited by applicant]
US 7112298B2 · Kampa et al. · 2006 [cited by applicant]
US 7329695B2 · Tucker et al. · 2008 [cited by applicant]
US 7455674B2 · Rose · 2008 [cited by applicant]
US 7485670B2 · Ruberti et al. · 2009 [cited by applicant]
US 7553325B2 · Stinson · 2009 [cited by applicant]
US 7619009B2 · Ruberti et al. · 2009 [cited by applicant]
US 7631760B2 · Guelzow et al. · 2009 [cited by applicant]
US 7745532B2 · Ruberti et al. · 2010 [cited by applicant]
US 7845670B2 · Oberg · 2010 [cited by applicant]
US 8017139B2 · Thomas et al. · 2011 [cited by applicant]
US 8313760B2 · Hunter et al. · 2012 [cited by applicant]
US 8470035B2 · Cruise et al. · 2013 [cited by applicant]
US 8541484B2 · Choi et al. · 2013 [cited by applicant]
US 8637063B2 · Kopesky et al. · 2014 [cited by applicant]
US 8784893B2 · Daniloff et al. · 2014 [cited by applicant]
US 8821583B2 · Myung et al. · 2014 [cited by applicant]
US 9216268B2 · Liu et al. · 2015 [cited by applicant]
US 9700443B2 · Lumauig et al. · 2017 [cited by applicant]
US 10182985B2 · Bellinger et al. · 2019 [cited by applicant]
US 10471183B2 · Biggins et al. · 2019 [cited by applicant]
US 10485898B2 · Biggins et al. · 2019 [cited by applicant]
US 11389570B2 · Biggins et al. · 2022 [cited by applicant]
US 11577008B2 · Bassett et al. · 2023 [cited by applicant]
US 11992627B2 · Bassett et al. · 2024 [cited by applicant]
US 12194198B2 · Mannarino et al. · 2025 [cited by applicant]
US 20010002411A1 · Ronan et al. · 2001 [cited by applicant]
US 20020055710A1 · Tuch · 2002 [cited by applicant]
US 20020138154A1 · Li et al. · 2002 [cited by applicant]
US 20040092653A1 · Ruberti et al. · 2004 [cited by applicant]
US 20040247867A1 · Chaouk et al. · 2004 [cited by applicant]
US 20050268573A1 · Yan · 2005 [cited by applicant]
US 20060205862A1 · Muller et al. · 2006 [cited by applicant]
US 20060240059A1 · Bavaro et al. · 2006 [cited by applicant]
US 20060287650A1 · Cao et al. · 2006 [cited by applicant]
US 20070129690A1 · Rosenblatt et al. · 2007 [cited by applicant]
US 20080065010A1 · Bavaro et al. · 2008 [cited by applicant]
US 20080075628A1 · Judd et al. · 2008 [cited by applicant]
US 20080160062A1 · Richard et al. · 2008 [cited by applicant]
US 20080208347A1 · Muratoglu et al. · 2008 [cited by applicant]
US 20090010983A1 · Melvik et al. · 2009 [cited by applicant]
US 20090075267A1 · Siena et al. · 2009 [cited by applicant]
US 20090076495A2 · Dando et al. · 2009 [cited by applicant]
US 20100087788A1 · Rosenblatt et al. · 2010 [cited by applicant]
US 20100105801A1 · Choi · 2010 [cited by applicant]
US 20100106103A1 · Ziebol et al. · 2010 [cited by applicant]
US 20100145286A1 · Zhang et al. · 2010 [cited by applicant]
US 20100152708A1 · Li et al. · 2010 [cited by applicant]
US 20100204800A1 · Thomas et al. · 2010 [cited by applicant]
US 20100210752A1 · Muratoglu et al. · 2010 [cited by applicant]
US 20100234815A1 · Do et al. · 2010 [cited by applicant]
US 20110000846A1 · Ishizuka et al. · 2011 [cited by applicant]
US 20110027181A1 · Amodei et al. · 2011 [cited by applicant]
US 20110091515A1 · Zilberman et al. · 2011 [cited by applicant]
US 20110190683A1 · Gellman et al. · 2011 [cited by applicant]
US 20110244010A1 · Doshi · 2011 [cited by applicant]
US 20130046346A1 · Thorwarth et al. · 2013 [cited by applicant]
US 20130338431A1 · Shalon et al. · 2013 [cited by applicant]
US 20140045398A1 · Zhang et al. · 2014 [cited by applicant]
US 20140058251A1 · Stigall et al. · 2014 [cited by applicant]
US 20140178446A1 · Zhu et al. · 2014 [cited by applicant]
US 20140287179A1 · Kamioka et al. · 2014 [cited by applicant]
US 20160015863A1 · Gupta et al. · 2016 [cited by applicant]
US 20160136389A1 · Christian et al. · 2016 [cited by applicant]
US 20160175483A1 · Zeitels et al. · 2016 [cited by applicant]
US 20170143952A1 · Siess et al. · 2017 [cited by applicant]
US 20170173219A1 · Biggins et al. · 2017 [cited by applicant]
US 20170182223A1 · Biggins et al. · 2017 [cited by applicant]
US 20170340867A1 · Acisano, III · 2017 [cited by applicant]
US 20180200185A1 · Labib et al. · 2018 [cited by applicant]
US 20180250116A1 · Mourhatch et al. · 2018 [cited by applicant]
US 20180369454A1 · Mannarino et al. · 2018 [cited by applicant]
US 20190167942A1 · Schonfeldt · 2019 [cited by applicant]
US 20200093965A1 · Biggins et al. · 2020 [cited by applicant]
US 20200205959A1 · Mourhatch · 2020 [cited by examiner]
US 20200230295A1 · Mannarino · 2020 [cited by examiner]
US 20210069468A1 · Keating et al. · 2021 [cited by applicant]
US 20220088348A1 · Bassett et al. · 2022 [cited by applicant]
US 20220378984A1 · Biggins et al. · 2022 [cited by applicant]
US 20230256141A1 · Bassett et al. · 2023 [cited by applicant]
US 20240399110A1 · Bassett et al. · 2024 [cited by applicant]
CN 1579601A · 2005 [cited by applicant]
CN 102580145A · 2012 [cited by applicant]
CN 102634865A · 2012 [cited by applicant]
EP 0532037A1 · 1993 [cited by applicant]
EP 2075014B1 · 2011 [cited by applicant]
GB 2203158A · 1988 [cited by examiner]
JP S5221420A · 1977 [cited by applicant]
JP S55106162A · 1980 [cited by applicant]
JP S58014906A · 1983 [cited by applicant]
JP S61226061A · 1986 [cited by applicant]
JP S6211460A · 1987 [cited by applicant]
JP H01299564A · 1989 [cited by applicant]
JP H10306191A · 1998 [cited by applicant]
JP H11130929A · 1999 [cited by applicant]
JP 2001500414A · 2001 [cited by applicant]
JP 2002360685A · 2002 [cited by applicant]
JP 2003507096A · 2003 [cited by applicant]
JP 2007500764A · 2007 [cited by applicant]
JP 2007501656A · 2007 [cited by applicant]
JP 2011072438A · 2011 [cited by applicant]
JP 2012251057A · 2012 [cited by applicant]
JP 2012532677A · 2012 [cited by applicant]
JP 5820918B1 · 2015 [cited by applicant]
JP 2016210992A · 2016 [cited by applicant]
JP 2014065681A · 2017 [cited by applicant]
JP 2017141477A · 2017 [cited by applicant]
JP 2020500068A · 2020 [cited by applicant]
KR 20180110695A · 2018 [cited by applicant]
WO WO9207899A2 · 1992 [cited by applicant]
WO WO9741180A1 · 1997 [cited by applicant]
WO WO9944665A2 · 1999 [cited by applicant]
WO WO0168746A1 · 2001 [cited by applicant]
WO WO2007002004A2 · 2007 [cited by applicant]
WO WO2012032881A1 · 2012 [cited by applicant]
WO WO2012122023A2 · 2012 [cited by applicant]
WO WO2014063711A1 · 2014 [cited by applicant]
WO WO2014077886A1 · 2014 [cited by applicant]
WO WO2017112878A1 · 2017 [cited by applicant]
WO WO2018237166A1 · 2018 [cited by applicant]
WO WO2021168284A1 · 2021 [cited by applicant]
U.S. Appl. No. 16/586,787, filed Sep. 27, 2019, Biggins et al. [cited by applicant]
U.S. Appl. No. 16/014,886, filed Jun. 21, 2018, Mannarino et al. [cited by applicant]
U.S. Appl. No. 16/719,753, filed Dec. 18, 2019, Mannarino et al. [cited by applicant]
PCT/US2021/021064, May 7, 2021, International Search Report and Written Opinion. [cited by applicant]
U.S. Appl. No. 17/841,813, filed Jun. 16, 2022, Biggins et al. [cited by applicant]
U.S. Appl. No. 17/944,966, filed Sep. 14, 2022, Bassett et al. [cited by applicant]
U.S. Appl. No. 17/361,025, filed Jun. 28, 2021, Bassett et al. [cited by applicant]
U.S. Appl. No. 18/640,689, filed Apr. 19, 2024, Bassett et al. [cited by applicant]
Hamada et al., Melting point of polyvinyl alcohol. Polym Chem. 1966;23(254):395-9. [cited by applicant]
International Search Report and Written Opinion for PCT/US2021/021064 mailed May 7, 2021. [cited by applicant]
[No Author Listed], Dimethyl Sulfoxide Physical Properties. Gaylord Chemical Company, L.L.C., Bulletin 101. Jun. 2014. 14 pages. [cited by applicant]
Chirila et al., Poly(2-hydroxyethyl methacrylate) sponges as implant materials: in vivo and in vitro evaluation of cellular invasion. Biomaterials. 1993;14(1):26-38. [cited by applicant]
Fukumori et al., Significant Improvement of Mechanical Properties for Polyvinyl Alcohol Film Prepared from Freeze/Thaw Cycled Gel. Open J Org Polym Mater. Oct. 2013;3(4):110-6. [cited by applicant]
Kang, The synthesis of nanoporous hydrogels using sacrificial block copolymers. Dissertation. Massachusetts Institute of Technology. Jul. 21, 2006. 106 pages. [cited by applicant]
Peppas et al., Semicrystalline poly(vinyl alcohol) films and their blends with poly(acrylic acid) and poly(ethylene glycol) for drug delivery applications. Journal of Drug Delivery Science and Technology. 2004; 14(4):29… [cited by applicant]
Sandeman et al., Adsorption of anionic and cationic dyes by activated carbons, PVA hydrogels, and PVA/AC composite. J Colloid Interface Sci. Jun. 15, 2011;358(2):582-92. doi:10.1016/j.jcis.2011.02.031. Epub Feb. 17, 201… [cited by applicant]
Speybrouck et al., Successful superior thyroid artery embolisation using microporous beads. European Society for Vascular Surgery. 2012;24:e5-e6. [cited by applicant]